Welcome to LSN
Hi, we are LSN Partners
a Strategic Advisory firm advancing Life Science Innovation.
We leverage data to deliver actionable intelligence—synthesizing science, market dynamics, and strategic context to shape differentiated strategies and drive measurable outcomes. We are working with founders, executive teams, and family office investors to uncover the commercial potential of a new or emerging innovations in life science.
John Fair – Founder & Managing Director
FEATURES
What We Do
Business Development & Strategic Transactions
We identify, evaluate, and diligence strategic partnerships, licensing opportunities, and M&A transactions—grounded in data-driven intelligence to maximize value and strategic fit.
Market Access & Commercial Strategy
We integrate patient, payer, provider, and KOL market insights to shape pricing, access, and go-to-market strategies—ensuring your innovation is positioned for adoption and commercial success.
Company and Technology Evaluation
Investment opportunity assessments, screening and diligence support integrating RWE, primary and secondary insights.
Portfolio & Asset Strategy
We synthesize data across programs to prioritize assets, define positioning, and guide development strategy—aligning scientific potential with commercial opportunity.
Product & Platform Latent Value Discovery
We uncover latent value within your asset or brand—synthesizing scientific, clinical, and market insights to identify opportunities to drive growth.
Growth & Value Strategy
We help leadership teams define and execute growth strategies—aligning pipeline, partnerships, and capital to drive sustained value creation..
Experience Across Strategy, Transactions, Analytics and Value Creation
Selected Highlights
Advising on high-value transactions and strategic partnerships
Transactions & Strategic Engagements
Rx Partnerships | Women’s Health
Strategic Licensing & Commercial Agreements (> $800M)
Structured and supported category-defining partnerships with top-tier global pharmaceutical leaders in women’s health, aligning innovative assets with established commercial infrastructure and global reach.
Selected transactions include Bayer Healthcare and Organon
Consumer Health | Partnerships/M&A
Global Out-Licensing & Commercial Expansion
Global out-licensing, partnership and M&A strategies connected to leading consumer health brands, enabling national retail expansion and scaled commercial growth.
Selected transactions include J3 Bioscience + O Positiv Health
Dx | GTM & Corporate Strategy
Commercialization & Ecosystem Development
Led go-to-market strategic planning and drove partnerships opportunities with strategics and leading academic institutions to support adoption and scale of novel diagnostics.
Translating data and analytics into insights, strategy and execution
Strategic data, insights, and execution
Fundraising & Investor Engagement
Capital Formation & Investor Positioning
Led investor positioning, capital planning, and use-of-proceeds strategy supporting $150M+ in capital formation, engaging institutional investors and securing private financing from specialized VCs and family offices.
Includes IPO planning and strategic acquisitions
Oncology | Data & Insights Platform
Technology-Enabled Insight Generation
Launched, built, and commercialized a data-driven oncology insights platform, integrating novel data capture technologies to deliver real-world insights to pharmaceutical brands and institutional investors. Acquired by Synovate (now Ipsos).
Fractional Leadership
Interim C-Level Leadership (CEO, CBO, Commercial)
Served in multiple C-level and interim executive leadership roles, driving turnaround, commercialization, and growth initiatives with measurable growth and value creation.